Efficacy and safety of high-dose and personalized TBS on post-stroke cognitive impairment: A randomized controlled trial
This study highlights the efficacy and safety of high-dose iTBS targeting the individualized FCN for post-stroke cognitive recovery.
Authors
- Mengying Ding
- Ying Zhou (ORCID: https://orcid.org/0000-0001-7078-6721)
- Ruiqi Pan (ORCID: https://orcid.org/0009-0007-2654-8196)
- Jianting Huang (ORCID: https://orcid.org/0009-0005-6633-9300)
- Hesheng Liu (ORCID: https://orcid.org/0000-0002-7233-1509)
- Kaiyue Han (ORCID: https://orcid.org/0009-0009-1090-199X)
- Xinyu Duan
- Wenlong Su (ORCID: https://orcid.org/0000-0002-5647-3988)
- Wei Zhang (ORCID: https://orcid.org/0000-0003-4816-8390)
- Jiajie Liu (ORCID: https://orcid.org/0000-0002-2927-1133)
- Haitao Lu (ORCID: https://orcid.org/0000-0002-1775-9780)
- Hao Zhang (ORCID: https://orcid.org/0000-0001-8546-3757)
- Ping Zhang (ORCID: https://orcid.org/0000-0003-0858-8884)
- Jian Sun (ORCID: https://orcid.org/0000-0003-1542-4220)
- Jianxun Ren (ORCID: https://orcid.org/0000-0002-7885-4546)
- Yafei Zhu (ORCID: https://orcid.org/0009-0000-1002-0708)
- Wuxiang Xie (ORCID: https://orcid.org/0000-0001-7527-1022)
Institutions
- Peking University (CN)
- Beijing Normal University (CN)
- China Rehabilitation Research Center (CN)
- Galaxy Biotech (United States) (US)
- Center for Life Sciences (CN)
Publication Details
- Journal
- Brain stimulation
- Published
- 2025-02-18
- DOI
- https://doi.org/10.1016/j.brs.2025.02.009
- Citations
- 20
- Primary Topic
- Transcranial Magnetic Stimulation Studies
- Type
- article
- Field-Weighted Citation Impact
- 16.84